Publications

December 5, 2007

The 25th annual Hit ’Em for Hemophilia Golf Tournament sponsored by Hemophilia of Georgia raised more than $350,000 for research for a cure for inherited bleeding disorders. Over 250 golfers participated in the tournament on October 30, 2007 at Château Élan Resort and Winery in Braselton, Georgia.

Sixty-seven companies contributed to the success of the 25th annual tournament by serving as corporate sponsors or by providing products and services. AT&T Mobility, LLC was the tournament’s Platinum Sponsor. Silver Sponsors included Baxter Healthcare Corporation, Bayer HealthCare, Crown Castle International, CSL Behring, LLC, Syniverse Technologies, TruePosition, Inc. and Wyeth Pharmaceuticals. Sponsors at the Bronze level included Ericsson and Novo Nordisk Pharmaceuticals, Inc.  Hemophilia of Georgia sincerely thanks all of the companies who participated in the tournament.

Hewlett-Packard served as Official Team Prize Sponsor and provided prizes for each member of the first, second, and third-place finishing teams on each of the three golf courses at Château Élan. The winning golfers were thrilled to receive the donated prizes which included digital cameras and printers. Hewlett-Packard also donated a laptop computer and other raffle prizes.

Each year, dozens of volunteers assist in the planning and on-site coordination of the Hit ’Em for Hemophilia Golf Tournament. This year, a record 80 volunteers gave a combined total of 920 volunteer hours in support of the tournament. Comments from volunteers included:

• “Good cause. I thoroughly enjoyed myself.”
• “I love helping such a worthy organization who truly appreciates its volunteers.”
• “HoG represents what I strive for: excellence!”

Hemophilia of Georgia is a nonprofit organization dedicated to providing services and support for Georgians who have hemophilia, von Willebrand Disease, and other inherited bleeding disorders. The only agency of its kind in the state, Hemophilia of Georgia works to enhance clients’ care and quality of life while actively pursuing a cure through research funding. HoG’s nonprofit pharmacy provides convenient home delivery of clotting factor and other medications at competitive prices. The agency’s mission states that Hemophilia of Georgia exists so that people in Georgia affected by bleeding disorders live as normally and productively as possible. Additional information is available online at www.hog.org.

Hemophilia is a hereditary genetic disorder in which a person’s blood is not able to clot normally. In normal blood, proteins called clotting factors work together to form a clot whenever bleeding occurs. The person with hemophilia lacks or doesn’t have enough of a certain clotting factor so the blood can’t make a clot. Hemophilia is a very rare disorder, affecting about 17,000 people in the United States. People with hemophilia stop bleeding by taking an injection of the clotting factor that is missing from their blood. However, the clotting factor used to treat hemophilia is very expensive. Some patients reach their lifetime insurance maximum at very young ages.